Home / Import refusals / 1FX-8122331-5/10002/2

FDA Import Refusal 1FX-8122331-5/10002/2 — CIPLA PHARMA LTD

CIPLA PHARMA LTD — FEI 3041524050

The FDA refused shipment 1FX-8122331-5/10002/2 from CIPLA PHARMA LTD (India) on Aug 31, 2026. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 2 other import refusals on record.

Refusal Details

Date
Aug 31, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61XCB45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
Charges
75

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.